Pancreatic cancer is one of the deadliest of all cancers. Only 12% of men diagnosed with pancreatic cancer are alive five ...

【导读】胰腺癌肝转移是导致预后不良的一个重要因素。肝转移中适应性免疫重塑的细节，尤其是中性粒细胞的作用，仍然难以捉摸。在这项研究中，单细胞测序与空间转录组学相结合的结果显示，与原发肿瘤相比，肝转移瘤表现出更具侵袭性的转录特征和更高水平的免疫抑制。20 ...

The new findings show the cancer mortality rate declined by 34% from 1991 to 2022 in the United States, averting ... Experimental Blood Test for Pancreatic Cancer Undergoing Clinical Development ...

A new advanced form of treatment for one of the deadliest cancers worldwide, pancreatic cancer, may be on its way, research ...

TLSs serve as the immune system’s on-site responders, forming in chronically inflamed tissues, including tumors, to bolster ...

Researchers identify distinct molecular and immune profiles that impact the prognosis of patients with metastatic pancreatic ductal adenocarcinoma.

Researchers from the University of Michigan have developed a way of detecting circulating tumor cells in the bloodstream of pancreatic cancer and lung cancer patients.

Many cancers upregulate an amino acid transporter to fuel their growth, making this protein a promising tool in tumor ...

With one of the lowest survival rates, pancreatic cancer urgently requires solutions. The enzyme Mical2, involved in the growth and spread of these tumors, could well become a prime target for future ...

Surufatinib plus TAS-102 showed promising survival benefits with manageable toxicity in refractory metastatic PDAC patients, ...